Umbilical cord-blood infections with Plasmodium falciparum malaria are acquired antenatally in Kenya

Journal of Infectious Diseases

Volumn 194, Issue 2, 2006, Pages 176-183

  Malhotra, Indu ^a   Mungai, Peter ^a   Muchiri, Eric ^d   Kwiek, Jesse J ^c   Meshnick, Steven R ^c   King, Christopher L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c IL   (United States)

^d Division of Vector Borne Diseases   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; FANSIDAR; GLUTAMINE; IMMUNOGLOBULIN E; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2;

ADULT; AMPLICON; ARTICLE; BLOOD SMEAR; CONTROLLED STUDY; DELIVERY; ENDEMIC DISEASE; FEMALE; FETOMATERNAL TRANSFUSION; GENOTYPE; HELMINTHIASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE INFECTION; KENYA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; MALE; MATERNAL BLOOD; NEWBORN; PARASITEMIA; PARITY; PLACENTAL TRANSFER; PLASMODIUM FALCIPARUM; PRENATAL EXPOSURE; PRIMIGRAVIDA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; UMBILICAL CORD BLOOD;

ANIMALS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL BLOOD; GENOTYPE; HUMANS; INFANT, NEWBORN; KENYA; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PREGNANCY; RISK FACTORS;

EID: 33746146350     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505150     Document Type: Article

References (33)

1. Beeson JG, Brown GV. Plasmodium falciparum-infected erythrocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate A and have distinct adhesive properties. J Infect Dis 2004; 189:169-79.
2. Duffy PE, Fried M. Malaria in the pregnant woman. Curr Top Microbiol Immunol 2005; 295:169-200.
3. Rogerson SJ, Pollina E, Getachew A, Tadesse E, Lema VM, Molyneux ME. Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg 2003; 68:115-9.
4. Ismail MR, Ordi J, Menendez C, et al. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol 2000; 31:85-93.
5. Covell G. Congenital malaria. Trop Dis Bull 1950; 47:1147-67.
6. Fischer PR. Congenital malaria: an African survey. Clin Pediatr (Phila) 1997; 36:411-3.
7. Tobian AA, Mehlotra RK, Malhotra I, et al. Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae, and P. ovale in Kenya. J Infect Dis 2000; 182:558-63.
8. Kamwendo DD, Dzinjalamala FK, Snounou G, et al. Plasmodium falciparum: PCR detection and genotyping of isolates from peripheral, placental, and cord blood of pregnant Malawian women and their infants. Trans R Soc Trop Med Hyg 2002; 96:145-9.
9. Xi G, Leke RG, Thuita LW, et al. Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in utero-produced antimalarial immunoglobulin M antibodies. Infect Immun 2003; 71:1242-6.
10. Kassberger F, Birkenmaier A, Khattab A, Kremsner PG, Klinkert MQ. PCR typing of Plasmodium falciparum in matched peripheral, placental and umbilical cord blood. Parasitol Res 2002; 88:1073-9.
11. Redd SC, Wirima JJ, Steketee RW, Breman JG, Heymann DL. Transplacental transmission of Plasmodium falciparum in rural Malawi. Am J Trop Med Hyg 1996; 55:57-60.
12. Malhotra I, Dent A, Mungai P, Muchiri E, King CL. Real-time quantitative PCR for determining the burden of Plasmodium falciparum parasites during pregnancy and infancy. J Clin Microbiol 2005; 43:3630-5.
13. Jakobsen PH, Rasheed FN, Bulmer JN, Theisen M, Ridley R, Greenwood BM. Inflammatory reactions in placental blood of Plasmodium falciparum-infected women and high concentrations of soluble E-selectin and a circulating P. falciparum protein in the cord sera. Immunology 1998; 93:264-9.
14. Thomas V, Chit CW. A case of congenital malaria in Malaysia with IgM malaria antibodies. Trans R Soc Trop Med Hyg 1980; 74:73-6.
15. King CL, Malhotra I, Wamachi A, et al. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J Immunol 2002; 168:356-64.
16. Desowitz RS, Elm J, Alpers MP. Plasmodium falciparum-specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternalcord sera from east Sepik Province, Papua New Guinea. Infect Immun 1993; 61:988-93.
17. Kirch AK, Agossou A, Banla M, Hoffmann WH, Schulz-Key H, Soboslay PT. Parasite-specific antibody and cytokine profiles in newborns from Plasmodium falciparum and Entamoeba histolytica/dispar-infected mothers. Pediatr Allergy Immunol 2004; 15:133-41.
18. Malhotra I, Mungai P, Muchiri E, et al. Distinct Th1- and Th2-type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun 2005; 73:3462-70.
19. Gallagher M, Malhotra I, Mungai PL, et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 2005; 19:1849-55.
20. Dorsey G, Njama D, Kamya MR, et al. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 2002; 360:2031-8.
21. Kaneda T, Shiraki K, Hirano K, Nagata I. Detection of maternofetal transfusion by placental alkaline phosphatase levels. J Pediatr 1997; 130:730-5.
22. Kwiek JJ, Mwapasa V, Milner DA Jr, et al. Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi. PLoS Med 2005;3:e10.
23. King CL, Poindexter RW, Ragunathan J, Fleisher TA, Ottesen EA, Nutman TB. Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels. J Immunol 1991; 146:1478-83.
24. Weil GJ, Hussain R, Kumaraswami V, Tripathy SP, Phillips KS, Ottesen EA. Prenatal allergic sensitization to helminth antigens in offspring of parasite-infected mothers. J Clin Invest 1983; 71:1124-9.
25. Lin HH, Kao JH, Hsu HY, Mizokami M, Hirano K, Chen DS. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996; 87:244-8.
26. + T cells based on cytokine secretion. Eur J Immunol 1999; 29:4053-9.
27. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine- pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998; 59:813-22.
28. Beeson JG, Duffy PE. The immunology and pathogenesis of malaria during pregnancy. Curr Top Microbiol Immunol 2005; 297:187-227.
29. Zarou D, Lichtman H, Hellman L. The transmission of chromium-51 tagged maternal erythrocytes from mother to fetus. Am J Obstet Gynecol 1964; 88:565-71.
30. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983; 61:1005-16.
31. Zhou A, Megnekou R, Leke R, et al. Prevalence of Plasmodium falciparum infection in pregnant Cameroonian women. Am J Trop Med Hyg 2002; 67:566-70.
32. Agbor-Enoh ST, Achur RN, Valiyaveettil M, Leke R, Taylor DW, Gowda DC. Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy. Infect Immun 2003; 71:2455-61.
33. Malhotra I, Munga P, Wamachi A, et al. Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood. J Infect Dis 2006; 193:1005-13.